{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:26Z","timestamp":1791644426581,"version":"4.3.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Histoplasmosis poses a significant risk to HIV patients, particularly in regions with limited access to antiretroviral therapy. Antigen detection assays are crucial in these settings for timely diagnosis and treatment, which can reduce mortality. While commercial antigen detection kits have performed well in diagnosing histoplasmosis, their effectiveness in monitoring treatment remains unclear. This study aimed to evaluate the correlation between urine antigen levels and clinical response using the clarus Histoplasma Galactomannan (GM) enzyme immunoassays (EIA) kit. The study followed 27 HIV patients diagnosed with histoplasmosis over 24 weeks, measuring urinary Histoplasma antigen (Ag) levels and clinical outcomes. Patients received amphotericin B as induction therapy, followed by maintenance with itraconazole. Results showed a significant decrease in Ag levels over time, with clinical scores improving in correlation with the decline in Ag levels. Four patients exhibited atypical Ag patterns due to immune reconstitution inflammatory syndrome or issues with itraconazole bioavailability. Despite these challenges, all patients showed improvement by week 24. The findings suggest that the clarus Histoplasma GM EIA kit could be a valuable tool for monitoring and evaluating the response to antifungal therapy in histoplasmosis patients.<\/jats:p>","DOI":"10.1093\/mmy\/myae121","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T02:30:33Z","timestamp":1734661833000},"source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of a commercial <i>Histoplasma<\/i> antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-7851","authenticated-orcid":false,"given":"Fernando A","family":"Messina","sequence":"first","affiliation":[{"name":"Unidad Micolog\u00eda, Hospital de Enfermedades Infecciosas Dr. Francisco J. Mu\u00f1iz, CABA ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1925-9835","authenticated-orcid":false,"given":"Emmanuel","family":"Marin","sequence":"additional","affiliation":[{"name":"Unidad Micolog\u00eda, Hospital de Enfermedades Infecciosas Dr. Francisco J. Mu\u00f1iz, CABA ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-9809","authenticated-orcid":false,"given":"Diego H","family":"Caceres","sequence":"additional","affiliation":[{"name":"Immuno-Mycologics (IMMY) , Norman, Oklahoma ,","place":["USA"]},{"name":"Center of Expertise in Mycology Radboudumc\/CWZ , Nijmegen ,","place":["The Netherlands"]},{"name":"Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, Universidad del Rosario , Bogota ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Romero","sequence":"additional","affiliation":[{"name":"Unidad Micolog\u00eda, Hospital de Enfermedades Infecciosas Dr. Francisco J. Mu\u00f1iz, CABA ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Manrique","sequence":"additional","affiliation":[{"name":"Unidad Micolog\u00eda, Hospital de Enfermedades Infecciosas Dr. Francisco J. Mu\u00f1iz, CABA ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Maria","family":"Santiso","sequence":"additional","affiliation":[{"name":"Unidad Micolog\u00eda, Hospital de Enfermedades Infecciosas Dr. Francisco J. Mu\u00f1iz, CABA ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"2025021015302913100_bib1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses","volume":"185","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"},{"issue":"5","key":"2025021015302913100_bib2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/jof9050558","article-title":"Tackling histoplasmosis infection in people living with HIV from Latin America: from diagnostic strategy to public health solutions","volume":"9","author":"C\u00e1ceres","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2025021015302913100_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jof6010003","article-title":"Histoplasmosis in persons living with HIV","volume":"6","author":"Nacher","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2025021015302913100_bib4","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/B978-1-4557-4801-3.00265-4","article-title":"265\u2014Histoplasma capsulatum (Histoplasmosis) A2 - Bennett, John E","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Deepe","year":"2015","edition":"8th edn"},{"issue":"3","key":"2025021015302913100_bib5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/jof5030076","article-title":"Diagnosis of progressive disseminated histoplasmosis in advanced HIV: a meta-analysis of assay analytical performance","volume":"5","author":"Caceres","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"2025021015302913100_bib6","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/tmi.13663","article-title":"Review of diagnostic methods and results for HIV-associated disseminated histoplasmosis: pathologists are not sufficiently involved","volume":"26","author":"Nacher","year":"2021","journal-title":"Trop Med Int Health"},{"issue":"6","key":"2025021015302913100_bib7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1128\/jcm.02430-16","article-title":"Laboratory diagnostics for histoplasmosis","volume":"55","author":"Azar","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2025021015302913100_bib8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccm.2017.04.004","article-title":"Clinical perspectives in the diagnosis and management of histoplasmosis","volume":"38","author":"Azar","year":"2017","journal-title":"Clin Chest Med"},{"issue":"6","key":"2025021015302913100_bib9","first-page":"863","article-title":"Evaluation of an enzyme immunoassay technique on detecting urinary Histoplasma capsulatum antigen in the diagnosis of disseminated histoplasmosis in Argentina","volume":"83","author":"Marin","year":"2023","journal-title":"Medicina"},{"issue":"5","key":"2025021015302913100_bib10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.4067\/s0716-10182018000500560","article-title":"Histoplasmosis in AIDS patients without tegumentary manifestations","volume":"35","author":"Messina","year":"2018","journal-title":"Rev Chilena Infectol"},{"issue":"8","key":"2025021015302913100_bib11","doi-asserted-by":"publisher","first-page":"e0001861","DOI":"10.1371\/journal.pgph.0001861","article-title":"Cost-effectiveness evaluation of routine histoplasmosis screening among people living with advanced HIV disease in Latin America and the Caribbean","volume":"3","author":"Rajasingham","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"2025021015302913100_bib12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/myc.13554","article-title":"Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil","volume":"66","author":"Blan","year":"2023","journal-title":"Mycoses"},{"issue":"1","key":"2025021015302913100_bib13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12981-021-00377-5","article-title":"Closing gaps in histoplasmosis: clinical characteristics and factors associated with probable\/histoplasmosis in HIV\/AIDS hospitalized patients, a retrospective cross-sectional study in two tertiary centers in Pereira, Colombia","volume":"18","author":"Hoyos\u00a0Pulgarin","year":"2021","journal-title":"AIDS Res Ther"},{"key":"2025021015302913100_bib14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/mmy\/myab022","article-title":"Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease","volume":"59","author":"Vidal","year":"2021","journal-title":"Med Mycol"},{"issue":"12","key":"2025021015302913100_bib15","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/microorganisms9122596","article-title":"Incidence of histoplasmosis in a cohort of people with HIV: from estimations to reality","volume":"9","author":"Medina","year":"2021","journal-title":"Microorganisms"},{"issue":"10","key":"2025021015302913100_bib16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jof7100799","article-title":"Validation and concordance analysis of a new lateral flow assay for detection of Histoplasma antigen in urine","volume":"7","author":"C\u00e1ceres","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"2025021015302913100_bib17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/myc.13368","article-title":"Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador","volume":"64","author":"Forno","year":"2021","journal-title":"Mycoses"},{"issue":"11","key":"2025021015302913100_bib18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/myc.13303","article-title":"Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV","volume":"64","author":"Caceres","year":"2021","journal-title":"Mycoses"},{"issue":"3","key":"2025021015302913100_bib19","doi-asserted-by":"crossref","first-page":"e0009215","DOI":"10.1371\/journal.pntd.0009215","article-title":"Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in patients living with HIV\/AIDS: a prospective multicenter study in Mexico","volume":"15","author":"Mart\u00ednez-Gamboa","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2025021015302913100_bib20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/myc.13023","article-title":"Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS","volume":"63","author":"C\u00e1ceres","year":"2020","journal-title":"Mycoses"},{"issue":"11","key":"2025021015302913100_bib21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/qad.0000000000002631","article-title":"Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV","volume":"34","author":"Medina","year":"2020","journal-title":"AIDS"},{"issue":"4","key":"2025021015302913100_bib22","doi-asserted-by":"publisher","first-page":"ofz073","DOI":"10.1093\/ofid\/ofz073","article-title":"Histoplasmosis, an underdiagnosed disease affecting people living with HIV\/AIDS in Brazil: results of a multicenter prospective cohort study using both classical mycology tests and Histoplasma urine antigen detection","volume":"6","author":"Falci","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025021015302913100_bib23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/myc.12902","article-title":"Can urinary Histoplasma antigen test improve the diagnosis of histoplasmosis in a tuberculosis endemic region?","volume":"62","author":"Bansal","year":"2019","journal-title":"Mycoses"},{"issue":"6","key":"2025021015302913100_bib24","doi-asserted-by":"publisher","first-page":"e01959","DOI":"10.1128\/jcm.01959-17","article-title":"Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV\/AIDS in two Latin American countries","volume":"56","author":"C\u00e1ceres","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2025021015302913100_bib25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/jof7020134","article-title":"Summary of guidelines for managing histoplasmosis among people living with HIV","volume":"7","author":"Perez","year":"2021","journal-title":"J Fungi"},{"key":"2025021015302913100_bib26","article-title":"Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV","author":"PAHO\/WHO","year":"2020"},{"issue":"9","key":"2025021015302913100_bib27","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1128\/cvi.00101-14","article-title":"Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy","volume":"21","author":"Caceres","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"2025021015302913100_bib28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2025021015302913100_bib29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/s-0035-1562899","article-title":"Histoplasmosis: up-to-date evidence-based approach to diagnosis and management","volume":"36","author":"Hage","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"2025021015302913100_bib30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/cvi.00389-10","article-title":"Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay","volume":"18","author":"Hage","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"1b","key":"2025021015302913100_bib31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0002-9343(83)90513-2","article-title":"Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience","volume":"74","author":"Restrepo","year":"1983","journal-title":"Am J Med"},{"issue":"Rr-4","key":"2025021015302913100_bib32","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"2025021015302913100_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/jof6040275","article-title":"Coronavirus disease 2019 (COVID-19) in a patient with disseminated histoplasmosis and HIV-A case report from Argentina and Literature Review","volume":"6","author":"Messina","year":"2020","journal-title":"J Fungi"},{"key":"2025021015302913100_bib34","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1093\/jac\/dkae264","article-title":"A multicentre study of amphotericin B treatment for histoplasmosis: assessing mortality rates and adverse events","volume":"79","author":"Sekiguchi","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2025021015302913100_bib35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12879-024-09257-5","article-title":"Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay","volume":"24","author":"Aguilar","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2025021015302913100_bib36","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/jcm.03175-14","article-title":"Reevaluation of commercial reagents for detection of Histoplasma capsulatum antigen in urine","volume":"53","author":"Theel","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2025021015302913100_bib37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/applmicrobiol2040072","article-title":"Validation of a lateral flow assay for rapid diagnosis of histoplasmosis in advanced HIV disease, Buenos Aires, Argentina","volume":"2","author":"Andreani","year":"2022","journal-title":"Appl Microbiol"},{"key":"2025021015302913100_bib38","doi-asserted-by":"publisher","first-page":"100403","DOI":"10.1016\/j.ijregi.2024.100403","article-title":"Rapid CD4 cell count determination and Cryptococcus and Histoplasma antigen detection in people living with HIV: implementation of a package of care strategy in a pilot study,\u00a0Argentina","volume":"12","author":"Andreani","year":"2024","journal-title":"IJID Reg"},{"issue":"3","key":"2025021015302913100_bib39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4269\/ajtmh.15-0108","article-title":"Implementation of a training course increased the diagnosis of histoplasmosis in Colombia","volume":"93","author":"Caceres","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"2025021015302913100_bib40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/jof7040268","article-title":"A rapid screening program for histoplasmosis, tuberculosis, and cryptococcosis reduces mortality in HIV patients from Guatemala","volume":"7","author":"Medina","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"2025021015302913100_bib41","doi-asserted-by":"publisher","first-page":"ofz534","DOI":"10.1093\/ofid\/ofz534","article-title":"The diagnostic laboratory hub: a new health care system reveals the incidence and mortality of tuberculosis, histoplasmosis, and cryptococcosis of PWH in Guatemala","volume":"7","author":"Samayoa","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae121\/61240452\/myae121.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/1\/myae121\/61240452\/myae121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/1\/myae121\/61240452\/myae121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:30:44Z","timestamp":1739201444000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae121\/7928999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,27]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae121","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,19]]},"article-number":"myae121"}}